Stock & Company Details
Fate Therapeutics Inc $FATE
Price:
N/A
N/A
120M
$260M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FATE technical indicators
Latest Fate Therapeutics Inc (FATE) indicator readings as of 2026-10-29.
FATE's 14-day RSI is 50.5, in neutral territory. At $2.17 it is trading 11.2% above its 200-day moving average of $1.95, and below its 50-day average of $2.30. Price sits in the middle of its Bollinger Bands ($1.80 to $2.39). ADX reads 9.2, indicating a range-bound market rather than a trend.
Overview
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Finance Bot
Ask your questions
Start by typing a question below.
